enVVeno Medical Corp Asset Resilience Ratio
enVVeno Medical Corp asset resilience ratio. enVVeno Medical Corp (NVNO) has an Asset Resilience Ratio of 90.90% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See enVVeno Medical Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of enVVeno Medical Corp (2021–2024)
Asset resilience ratio of enVVeno Medical Corp from 2021 to 2024. This chart shows how enVVeno Medical Corp's Asset Resilience Ratio has changed over time. Read NVNO total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down enVVeno Medical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see enVVeno Medical Corp total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $29.41 Million | 90.9% |
| Total Liquid Assets | $29.41 Million | 90.90% |
Asset Resilience Insights
- Very High Liquidity: enVVeno Medical Corp maintains exceptional liquid asset reserves at 90.90% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
enVVeno Medical Corp Industry Peers by Asset Resilience Ratio
Compare enVVeno Medical Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
enVVeno Medical Corp Asset Resilience Ratio by Year (2021–2024)
enVVeno Medical Corp asset resilience ratio by year from 2021 to 2024. The table below shows the annual Asset Resilience Ratio data for enVVeno Medical Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 92.09% | $41.40 Million | $44.95 Million | +4.11pp |
| 2023-12-31 | 87.99% | $42.79 Million | $48.63 Million | +5.20pp |
| 2022-12-31 | 82.78% | $34.49 Million | $41.66 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $57.70 Million | -- |
About enVVeno Medical Corp
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in … Read more